Organo Corp.

Organo Corp.

16.37
USD
-0.03
(-0.21%)
5.14BMarket Cap
Nov 04Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
269.49
298.38
341.75
352.21
344.1
402.55
421.83
438.7
488.34
577.49
654.79
710.37
772.81
- -
Basic EPS, GAAP
2.88
4.71
10.79
11.86
12.07
19.42
31.3
30.84
40.13
51.15
75.38
105.07
123.55
- -
Free Cash Flow per Basic Share
30.74
-13.18
-23.88
22.85
-2.27
21.94
33.15
-25.44
34.81
-87.16
9.05
80.1
44.47
- -
Dividend per Share
2.5
2
2
2.5
2.75
2.86
4.58
5.47
6.71
10.23
14.83
26.43
36.83
- -
Book Value per Share
192.06
196.68
201.72
212.36
223.88
239.24
265.06
292.81
331.03
375.55
443.7
526.24
621.81
621.81
Tangible Book Value per Share
190.45
194.67
198.82
207.99
218.78
233.95
260.2
288
326.3
371.42
439.41
521.37
614.97
614.97
Basic Weighted Avg Shares
230
230
230
230
230
229
229
229
229
229
230
230
230
230
Sales/Revenue/Turnover
62,096
68,741
78,719
81,114
79,226
92,273
96,515
100,638
112,069
132,426
150,356
163,269
177,654
- -
Operating Margin (%)
1.34
3.49
5.02
23
4.82
7.11
10.27
9.52
9.68
11.49
14.99
19.06
21.19
- -
Depreciation Expense
1,065
999
950
950
972
920
1,189
1,212
1,332
1,824
2,010
1,925
1,981
- -
Net Income, GAAP
664
1,085
2,485
2,731
2,780
4,452
7,162
7,074
9,210
11,730
17,310
24,150
28,401
- -
Effective Tax Rate (%)
43.05
44.76
34.81
31.08
28.39
30.05
27.19
26.9
27.33
26.63
26.65
25.25
25.86
- -
Profit Margin (%)
1.07
1.58
3.16
3.37
3.51
4.82
7.42
7.03
8.22
8.86
11.51
14.79
15.99
- -
Working Capital
26,941
31,063
32,407
32,965
33,333
36,107
43,838
48,953
59,790
68,027
80,867
99,966
121,063
121,063
LT Debt
2,552
4,402
3,801
2,601
1,401
200
2,095
1,495
5,695
3,895
2,400
3,680
6,000
6,000
Total Equity
44,252
45,308
46,567
49,034
51,680
54,795
60,857
67,357
76,004
86,370
102,146
121,193
142,961
142,961
Return on Invested Capital (%)
0.82
2.34
4.18
4.31
4.06
6.64
10.12
8.86
8.83
10.36
12.5
15.99
16.78
- -
Return on Capital (%)
1.26
2
4.15
4.24
4.2
6.63
10.43
9.29
10.61
11.2
13.54
17.21
17.83
- -
Return on Common Equity (%)
1.49
2.42
5.42
5.73
5.54
8.38
12.42
11.06
12.88
14.48
18.41
21.67
21.52
- -

Capital Structure

JPY

•

in mil. unless spec.
Jun'26
Sep'26
Mar'26
ST Debt
- -
13,165
28,402
LT Borrowings
- -
7,600
6,000
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
230
230
230
Market Capitalization
- -
- -
815,887

Working Capital

JPY

•

in mil. unless spec.
Jun'26
Sep'26
Mar'26
Total Current Assets
- -
164,298
192,002
Cash, Cash Equivalents & STI
- -
49,597
84,911
Accounts Receivable, Net
- -
72,547
47,989
Inventories
- -
31,086
18,563
Total Current Liabilities
- -
53,571
70,939
Payables & Accruals
- -
- -
- -
ST Debt
- -
13,165
28,402
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
11.98%
16.27%
17.96%
Free Cash Flow
-145.13%
8.72%
-44.47%
Net Income, GAAP
29.37%
32.45%
17.6%
Sales/Revenue/Turnover
8.65%
12.09%
8.81%
Total Cash Common Dividend
35.61%
47.61%
39.4%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
29,612
35,857
40,767
44,120
150,356
2025
- -
- -
- -
- -
163,269
2026
- -
- -
- -
- -
177,654

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
6.96
17.16
20.51
30.73
75.38
2025
- -
- -
- -
- -
105.07
2026
- -
- -
- -
- -
123.55

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
14.83
2025
- -
- -
- -
- -
26.43
2026
- -
- -
- -
- -
36.83

Company Description

CEO
Masayuki Yamada
Full Time Employees
2,658
Sector
Producer manufacturing
Industry
Industrial machinery
Address
1-2-8, Shinsuna Tokyo Japan 136-8631
IPO Date
Oct 2, 1961
Business
Organo Corporation (6368.T) engages primarily in water treatment engineering and functional products businesses, designing, constructing, and maintaining water purification systems for industrial, municipal, and specialized applications worldwide. The company offers an extensive portfolio of core products and services, including pure water systems such as reverse osmosis (RO) systems, regenerative automatic and manual pure water systems, electric regeneration pure water systems, desktop-type and cabinet-type pure water systems, electrodeionization high-purity water systems, and two-stage RO systems; ultrapure water systems comprising desktop and cabinet-type ultrapure water systems and final polishing units; other equipment like alkaline electrolyzed water production equipment, homogenizers, electro conductivity meters, resistivity meters, ion exchange filters, and marine scrubber wastewater treatment systems; water, wastewater, and RO water treatment chemicals; industrial filters including micro filters, sanitary filters, polypropylene filters, plastic housings, RO wound cartridges, PF cartridges, capsule filters, and PF carbon filters; and commercial water purifiers. For specific industries, Organo provides ultrapure and multi-functional water production systems, wastewater treatment systems, valuable resource recovery systems for hydrofluoric acid, tetramethylammonium hydroxide (TMAH), and rare metals, and organic solvent refining systems tailored to electronics; purified water production and supply systems, ultrafiltration (UF) water systems, water for injection systems, and pharmaceutical water consulting for pharmaceuticals, cosmetics, and medical devices; condensate filters, demineralizers, reactor water cleanup, fuel pool cleanup, makeup water, and wastewater treatment for energy and power generation; as well as sugar refining systems and equipment for food processing. Founded in 1946 and headquartered in Tokyo, Japan, Organo Corporation operates across Japan, Taiwan, China, Southeast Asia, and other international markets, serving sectors such as semiconductors, flat panel displays, pharmaceuticals, power generation, water supply, sewage treatment, and sugar production with comprehensive in-house capabilities spanning product development, design, construction, sales, and after-sales service. The company maintains research and development centers, factories, and sales offices to support its global footprint and positions itself as a one-stop solution provider for ultrapure water, pure water, industrial wastewater, sewerage, and resource recovery needs. In recent developments, Organo Corporation announced organizational restructuring and changes in officers during 2025, alongside releasing financial results and notices for shareholder meetings, reflecting ongoing efforts to adapt its structure amid evolving water treatment demands. The company continues to invest in technologies for resource recovery and membrane separation, including expansions in ultrapure water systems for semiconductor fabs with a U.S. presence established in 2021, while maintaining focus on sustainable practices in response to global water scarcity and stricter regulations. No major acquisitions, funding rounds, or new product launches were reported in the past 1-2 years, with operations emphasizing steady innovation in existing segments.